$TTPH Announces Positive Data from PostHoc Analysis of Phase 3 Trials Demonstrating Efficacy of XERAVA in Obese and Renally Impaired Patients with Complicated IntraAbdominal Infections httpsfinance.yahoo.comnewstetraphasepharmaceuticalsannounc

$TTPH Announces Positive Data from Post-Hoc Analysis of Phase 3 Trials Demonstrating Efficacy of XERAVA™ in Obese and Renally Impaired Patients with Complicated Intra-Abdominal Infections https://finance.yahoo.com/news/tetraphase-pharmaceuticals-announc

07:36 EDT 23 Oct 2018 | Odi Bruckman

$TTPH Announces Positive Data from Post-Hoc Analysis of Phase 3 Trials Demonstrating Efficacy of XERAVA™ in Obese and Renally Impaired Patients with Complicated Intra-Abdominal Infections https://finance.yahoo.com/news/tetraphase-pharmaceuticals-announces-positive-data-103000389.html …

More From BioPortfolio on "$TTPH Announces Positive Data from Post-Hoc Analysis of Phase 3 Trials Demonstrating Efficacy of XERAVA™ in Obese and Renally Impaired Patients with Complicated Intra-Abdominal Infections https://finance.yahoo.com/news/tetraphase-pharmaceuticals-announc"